Role of DNA methyltransferase 1 in pharyngeal cancer related to treatment resistance

Head and Neck

Volumn 33, Issue 8, 2011, Pages 1132-1143

  Chen, Chih Cheng ^a,b,c   Chen, Wen Cheng ^a,b   Wang, Wen Hung ^a,b   Lu, Chang Hsien ^a,b   Lin, Paul Yang ^a   Lee, Kuan Der ^a,b   Chen, Miao Fen ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

DNMT1; IL 6; pharyngeal cancer

Indexed keywords

BIOLOGICAL MARKER; DNA METHYLTRANSFERASE 1; FREE RADICAL; INTERLEUKIN 6 RECEPTOR;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CANCER THERAPY; CELL CYCLE ARREST; CYTOKINE PRODUCTION; DISEASE MARKER; DNA DAMAGE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHARYNX CANCER; PRIORITY JOURNAL; PROGNOSIS; THERAPY RESISTANCE; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REPRESSOR PROTEINS; SURVIVAL ANALYSIS; TREATMENT FAILURE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960401628     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21586     Document Type: Article

References (36)

1. Herman JG, Baylin SB,. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042-2054. (Pubitemid 37448928)
2. Robertson KD,. DNA methylation and chromatin-unraveling the tangled web. Oncogene 2002; 21: 5361-5379. (Pubitemid 34983473)
3. Hodge DR, Peng B, Cherry JC, et al. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res 2005; 65: 4673-4682. (Pubitemid 40740803)
4. Momparler RL, Bovenzi V,. DNA methylation and cancer. J Cell Physiol 2000; 183: 145-154. (Pubitemid 30185933)
5. Hermann A, Gowher H, Jeltsch A,. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 2004; 61: 2571-2587. (Pubitemid 39586518)
6. Bestor TH,. The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9: 2395-2402.
7. Robert MF, Morin S, Beaulieu N, et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 2003; 33: 61-65. (Pubitemid 36068683)
8. Hino R, Uozaki H, Murakami N, et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 2009; 69: 2766-2774.
9. De Marzo AM, Marchi VL, Yang ES, Veeraswamy R, Lin X, Nelson WG,. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res 1999; 59: 3855-3860. (Pubitemid 29393539)
10. Feinberg AP, Tycko B,. The history of cancer epigenetics. Nat Rev Cancer 2004; 4: 143-153. (Pubitemid 38198742)
11. Gius D, Cui H, Bradbury CM, et al. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 2004; 6: 361-371. (Pubitemid 39361437)
12. Yakushiji T, Uzawa K, Shibahara T, Noma H, Tanzawa H,. Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. Int J Oncol 2003; 22: 1201-1207.
13. Mishra MV, Bisht KS, Sun L, et al. DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells. Mol Cancer Res 2008; 6: 243-249. (Pubitemid 351342412)
14. Graham JS, Kaye SB, Brown R,. The promises and pitfalls of epigenetic therapies in solid tumours. Eur J Cancer 2009; 45: 1129-1136.
15. De Schutter H, Kimpe M, Isebaert S, Nuyts S,. A systematic assessment of radiation dose enhancement by 5-Aza-2′-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2009; 73: 904-912.
16. Chen CC, Chen WC, Lu CH, et al. Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor. Int J Radiat Oncol Biol Phys 2010; 76: 1214-1224.
17. Duffy SA, Taylor JM, Terrell JE, et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer 2008; 113: 750-757.
18. Zhang Q, Wang HY, Woetmann A, Raghunath PN, Odum N, Wasik MA,. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood 2006; 108: 1058-1064. (Pubitemid 44154645)
19. Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA,. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci U S A 2005; 102: 6948-6953. (Pubitemid 40675422)
20. Wehbe H, Henson R, Meng F, Mize-Berge J, Patel T,. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res 2006; 66: 10517-10524. (Pubitemid 44799774)
21. Lemaire M, Chabot GG, Raynal NJ, et al. Importance of dose-schedule of 5-aza-2′-deoxycytidine for epigenetic therapy of cancer. BMC Cancer 2008; 8: 128.
22. Mortusewicz O, Schermelleh L, Walter J, Cardoso MC, Leonhardt H,. Recruitment of DNA methyltransferase I to DNA repair sites. Proc Natl Acad Sci U S A 2005; 102: 8905-8909. (Pubitemid 40881051)
23. Tulard A, Hoffschir F, de Boisferon FH, Luccioni C, Bravard A,. Persistent oxidative stress after ionizing radiation is involved in inherited radiosensitivity. Free Radic Biol Med 2003; 35: 68-77. (Pubitemid 36782338)
24. Pollard JM, Gatti RA,. Clinical radiation sensitivity with DNA repair disorders: an overview. Int J Radiat Oncol Biol Phys 2009; 74: 1323-1331.
25. Conlon KA, Zharkov DO, Berrios M,. Immunofluorescent localization of the murine 8-oxoguanine DNA glycosylase (mOGG1) in cells growing under normal and nutrient deprivation conditions. DNA Repair (Amst) 2003; 2: 1337-1352. (Pubitemid 37464812)
26. Jones PA, Baylin SB,. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428. (Pubitemid 34587077)
27. Kassis ES, Zhao M, Hong JA, Chen GA, Nguyen DM, Schrump DS,. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells. J Thorac Cardiovasc Surg 2006; 131: 298-306.
28. Morey SR, Smiraglia DJ, James SR, et al. DNA methylation pathway alterations in an autochthonous murine model of prostate cancer. Cancer Res 2006; 66: 11659-11667. (Pubitemid 46094177)
29. Morey Kinney SR, Smiraglia DJ, James SR, Moser MT, Foster BA, Karpf AR,. Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Res 2008; 6: 1365-1374.
30. Hodge DR, Cho E, Copeland TD, et al. IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase. Cancer Genomics Proteomics 2007; 4: 387-398.
31. Lin J, Guan Z, Wang C, et al. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res 2010; 16: 77-87.
32. Garner E, Raj K,. Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death. Cell Cycle 2008; 7: 277-282. (Pubitemid 351366487)
33. Brown JM, Attardi LD,. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005; 5: 231-237. (Pubitemid 40314954)
34. Olive PL, Banáth JP,. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys 2004; 58: 331-335. (Pubitemid 38142456)
35. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM,. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273: 5858-5868. (Pubitemid 28124064)
36. Okada H, Mak TW,. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004; 4: 592-603. (Pubitemid 39025054)